OPK
Price
$1.36
Change
+$0.02 (+1.49%)
Updated
Jul 3 closing price
Capitalization
920.03M
27 days until earnings call
SSMXF
Price
$16.00
Change
-$1.10 (-6.43%)
Updated
Jul 3 closing price
Capitalization
14.31B
Interact to see
Advertisement

OPK vs SSMXF

Header iconOPK vs SSMXF Comparison
Open Charts OPK vs SSMXFBanner chart's image
OPKO Health
Price$1.36
Change+$0.02 (+1.49%)
Volume$1.03M
Capitalization920.03M
Sysmex
Price$16.00
Change-$1.10 (-6.43%)
Volume$105
Capitalization14.31B
OPK vs SSMXF Comparison Chart in %
Loading...
OPK
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SSMXF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
OPK vs. SSMXF commentary
Jul 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is OPK is a Buy and SSMXF is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 04, 2025
Stock price -- (OPK: $1.36 vs. SSMXF: $16.00)
Brand notoriety: OPK and SSMXF are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: OPK: 30% vs. SSMXF: 7%
Market capitalization -- OPK: $920.03M vs. SSMXF: $14.31B
OPK [@Medical Specialties] is valued at $920.03M. SSMXF’s [@Medical Specialties] market capitalization is $14.31B. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $8.58B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

OPK’s FA Score shows that 0 FA rating(s) are green whileSSMXF’s FA Score has 1 green FA rating(s).

  • OPK’s FA Score: 0 green, 5 red.
  • SSMXF’s FA Score: 1 green, 4 red.
According to our system of comparison, SSMXF is a better buy in the long-term than OPK.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

OPK’s TA Score shows that 6 TA indicator(s) are bullish while SSMXF’s TA Score has 2 bullish TA indicator(s).

  • OPK’s TA Score: 6 bullish, 2 bearish.
  • SSMXF’s TA Score: 2 bullish, 5 bearish.
According to our system of comparison, OPK is a better buy in the short-term than SSMXF.

Price Growth

OPK (@Medical Specialties) experienced а +3.03% price change this week, while SSMXF (@Medical Specialties) price change was +6.67% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was +1.93%. For the same industry, the average monthly price growth was +1.81%, and the average quarterly price growth was -0.17%.

Reported Earning Dates

OPK is expected to report earnings on Jul 31, 2025.

Industries' Descriptions

@Medical Specialties (+1.93% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
SSMXF($14.3B) has a higher market cap than OPK($920M). SSMXF has higher P/E ratio than OPK: SSMXF (42.74) vs OPK (26.11). OPK YTD gains are higher at: -7.483 vs. SSMXF (-17.184). SSMXF has higher annual earnings (EBITDA): 102B vs. OPK (-65.52M). SSMXF has more cash in the bank: 70.3B vs. OPK (95.9M). OPK has less debt than SSMXF: OPK (327M) vs SSMXF (22.6B). SSMXF has higher revenues than OPK: SSMXF (411B) vs OPK (863M).
OPKSSMXFOPK / SSMXF
Capitalization920M14.3B6%
EBITDA-65.52M102B-0%
Gain YTD-7.483-17.18444%
P/E Ratio26.1142.7461%
Revenue863M411B0%
Total Cash95.9M70.3B0%
Total Debt327M22.6B1%
FUNDAMENTALS RATINGS
OPK vs SSMXF: Fundamental Ratings
OPK
SSMXF
OUTLOOK RATING
1..100
2681
VALUATION
overvalued / fair valued / undervalued
1..100
68
Overvalued
17
Undervalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
90100
PRICE GROWTH RATING
1..100
6254
P/E GROWTH RATING
1..100
9976
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

SSMXF's Valuation (17) in the null industry is somewhat better than the same rating for OPK (68) in the Biotechnology industry. This means that SSMXF’s stock grew somewhat faster than OPK’s over the last 12 months.

SSMXF's Profit vs Risk Rating (100) in the null industry is in the same range as OPK (100) in the Biotechnology industry. This means that SSMXF’s stock grew similarly to OPK’s over the last 12 months.

OPK's SMR Rating (90) in the Biotechnology industry is in the same range as SSMXF (100) in the null industry. This means that OPK’s stock grew similarly to SSMXF’s over the last 12 months.

SSMXF's Price Growth Rating (54) in the null industry is in the same range as OPK (62) in the Biotechnology industry. This means that SSMXF’s stock grew similarly to OPK’s over the last 12 months.

SSMXF's P/E Growth Rating (76) in the null industry is in the same range as OPK (99) in the Biotechnology industry. This means that SSMXF’s stock grew similarly to OPK’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
OPKSSMXF
RSI
ODDS (%)
N/A
Bearish Trend 2 days ago
36%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
83%
Bullish Trend 2 days ago
36%
Momentum
ODDS (%)
Bullish Trend 2 days ago
76%
Bearish Trend 2 days ago
37%
MACD
ODDS (%)
Bullish Trend 2 days ago
77%
Bullish Trend 2 days ago
39%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
74%
Bullish Trend 2 days ago
37%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
77%
Bullish Trend 2 days ago
34%
Advances
ODDS (%)
Bullish Trend 2 days ago
74%
N/A
Declines
ODDS (%)
Bearish Trend 22 days ago
80%
N/A
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
85%
Bearish Trend 2 days ago
25%
Aroon
ODDS (%)
Bullish Trend 2 days ago
76%
Bearish Trend 2 days ago
52%
View a ticker or compare two or three
Interact to see
Advertisement
OPK
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SSMXF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
GSLC122.891.06
+0.87%
Goldman Sachs ActiveBeta® US LgCp Eq ETF
BHK9.760.02
+0.21%
Blackrock Core BD TR
HTEC28.790.01
+0.05%
Robo Global® Hlthcare Tech & Innovt ETF
MGRO31.70N/A
N/A
VanEck Morningstar Wide Moat Growth ETF
BSMT22.75-0.01
-0.02%
Invesco BulletShares 2029 Muncpl Bd ETF

OPK and

Correlation & Price change

A.I.dvisor indicates that over the last year, OPK has been loosely correlated with ICUI. These tickers have moved in lockstep 41% of the time. This A.I.-generated data suggests there is some statistical probability that if OPK jumps, then ICUI could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To OPK
1D Price
Change %
OPK100%
+1.49%
ICUI - OPK
41%
Loosely correlated
-0.54%
ZIMV - OPK
38%
Loosely correlated
+2.40%
XAIR - OPK
35%
Loosely correlated
+0.67%
CRL - OPK
35%
Loosely correlated
-0.23%
CLPT - OPK
34%
Loosely correlated
+3.63%
More

SSMXF and

Correlation & Price change

A.I.dvisor tells us that SSMXF and OPK have been poorly correlated (+20% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that SSMXF and OPK's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SSMXF
1D Price
Change %
SSMXF100%
-6.43%
OPK - SSMXF
20%
Poorly correlated
+1.49%
SONVY - SSMXF
4%
Poorly correlated
-1.34%
SONVF - SSMXF
3%
Poorly correlated
N/A
SMMNY - SSMXF
3%
Poorly correlated
-1.31%
SNWV - SSMXF
3%
Poorly correlated
-0.22%
More